Erste Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-48,600
| Closed | -$2M | – | 820 |
|
|
2023
Q2 | $2M | Hold |
48,600
| – | – | 0.04% | 289 |
|
|
2023
Q1 | $2.37M | Hold |
48,600
| – | – | 0.05% | 276 |
|
|
2022
Q4 | $1.8M | Hold |
48,600
| – | – | 0.04% | 288 |
|
|
2022
Q3 | $2.45M | Hold |
48,600
| – | – | 0.05% | 264 |
|
|
2022
Q2 | $1.96M | Hold |
48,600
| – | – | 0.04% | 283 |
|
|
2022
Q1 | $1.81M | Buy |
48,600
+6,800
| +16% | +$254K | 0.03% | 309 |
|
|
2021
Q4 | $1.7M | Hold |
41,800
| – | – | 0.03% | 309 |
|
|
2021
Q3 | $1.55M | Hold |
41,800
| – | – | 0.03% | 293 |
|
|
2021
Q2 | $1.76M | Hold |
41,800
| – | – | 0.04% | 295 |
|
|
2021
Q1 | $1.96M | Hold |
41,800
| – | – | 0.05% | 271 |
|
|
2020
Q4 | $2.65M | Sell |
41,800
-16,000
| -28% | -$1.02M | 0.07% | 238 |
|
|
2020
Q3 | $2.73M | Hold |
57,800
| – | – | 0.09% | 212 |
|
|
2020
Q2 | $2.93M | Buy |
57,800
+15,000
| +35% | +$760K | 0.12% | 184 |
|
|
2020
Q1 | $1.82M | Sell |
42,800
-35,500
| -45% | -$1.51M | 0.11% | 194 |
|
|
2019
Q4 | $3.82M | Hold |
78,300
| – | – | 0.17% | 136 |
|
|
2019
Q3 | $2.71M | Hold |
78,300
| – | – | 0.14% | 155 |
|
|
2019
Q2 | $3.38M | Buy |
+78,300
| New | +$3.38M | 0.18% | 133 |
|